Advances in Alzheimer’s disease diagnosis and therapeutic strategies: an integrative review of current evidence.
DOI:
https://doi.org/10.62452/3gxw6744Palavras-chave:
Alzheimer's disease, early diagnosis, biomarkers, disease-modifying therapies, precision medicine, neuroimagingResumo
Alzheimer's disease is the leading cause of dementia worldwide and represents one of the greatest challenges facing contemporary medicine because of its high prevalence, irreversible progression, and profound impact on patients, their families, and healthcare systems. The present study aimed to analyze recent scientific advances in the diagnosis and therapeutic strategies for Alzheimer's disease through an integrative review of specialized literature. To achieve this objective, a qualitative analysis of scientific publications was conducted. The findings reveal a significant transformation in the diagnostic paradigm, shifting from an approach based primarily on clinical assessment to one supported by biological biomarkers, advanced neuroimaging techniques, and precision medicine strategies capable of identifying neuropathological changes during the preclinical stages of the disease. Likewise, the literature demonstrates a substantial shift in treatment approaches, moving from symptomatic management toward interventions designed to modify disease progression. Important advances were also identified in the fields of artificial intelligence, nanotechnology, precision pharmacology, and the development of innovative drug discovery platforms. Although significant challenges remain regarding biological heterogeneity, clinical efficacy, safety, accessibility, and the implementation of these innovations, the available scientific evidence indicates that the future management of Alzheimer's disease will be based on early diagnosis, molecular patient stratification, and the development of personalized therapeutic strategies capable of delaying neurodegeneration and improving clinical outcomes.
Downloads
Referências
Chen, P.-H., & Hsu, J.-L. (2026). Alzheimer's disease diagnosis: An update and review of biomarkers, positron emission tomography, and emerging therapies. Journal of the Formosan Medical Association, 125(Suppl. 1), 13–16. https://doi.org/10.1016/j.jfma.2026.01.035
Cheng, H., Kang, L., Xu, Y., Tanzi, R. E., Zhang, C., & Wang, C. (2026). Innovation breakthrough in the Alzheimer’s disease pharmaceutical industry. npj Drug Discovery, 3, Article 9. https://doi.org/10.1038/s44386-026-00044-7
Hassan, N. A., Alshamari, A. K., Hassan, A. A., Elharrif, M. G., Alhajri, A. M., Sattam, M., & Khattab, R. R. (2022). Advances on Therapeutic Strategies for Alzheimer’s Disease: From Medicinal Plant to Nanotechnology. Molecules, 27(15), 4839. https://doi.org/10.3390/molecules27154839
Khan, T., Waseem, R., Shahid, M., Ansari, J., Ahanger, I. A., Hassan, I., & Islam, A. (2023). Recent advancement in therapeutic strategies for Alzheimer’s disease: Insights from clinical trials. Ageing Research Reviews, 92, Article 102113. https://doi.org/10.1016/j.arr.2023.102113
Kim, M., Kwon, H., Sohn, S., Lee, W. J., Cho, K., & Kim, G. W. (2025). Alzheimer's disease diagnosis and treatment: From pathophysiological insights to therapeutic advances in the era of precision neurology (2025 review). Journal of Alzheimer's Disease, 109(1). https://doi.org/10.1177/13872877251391820
Liu, N., Liang, X., Chen, Y., & Xie, L. (2024). Recent trends in treatment strategies for Alzheimer's disease and the challenges: A topical advancement. Ageing Research Reviews, 94, Article 102199. https://doi.org/10.1016/j.arr.2024.102199
Napoli, S., & Rafii, M. S. (2025, August 14). Early diagnosis and treatment of Alzheimer’s disease. Medscape. https://reference.medscape.com/viewarticle/alzheimers-early-diagnosis-management-2025a1000it1
Pang, R., Jia, Q., Ma, C., Li, T., Bi, W., Wang, H., Liu, R., Chen, P., Lee, E. S., & Jiang, H. B. (2025). Alzheimer's Disease: The Current and Emerging Treatment Approaches. Behavioural neurology, 2025, 9627699. https://doi.org/10.1155/bn/9627699
Peng, Y., Jin, H., Xue, Y.-H., Chen, Q., Yao, S.-Y., Du, M.-Q., & Liu, S. (2023). Current and future therapeutic strategies for Alzheimer’s disease: An overview of drug development bottlenecks. Frontiers in Aging Neuroscience, 15, Article 1206572. https://doi.org/10.3389/fnagi.2023.1206572
Rudman, M. D., Ulrich, J. D., & Holtzman, D. M. (2026). Recent advances in Alzheimer’s disease: From molecular mechanisms to therapeutic strategies. Cell, 189(14), 4193–4224. https://doi.org/10.1016/j.cell.2026.06.006
Safiri, S., Ghaffari Jolfayi, A., Fazlollahi, A., Morsali, S., Sarkesh, A., Daei Sorkhabi, A., Golabi, B., Aletaha, R., Asghari, K. M., Hamidi, S., Mousavi, S. E., Jamalkhani, S., Karamzad, N., ... & Kolahi, A.-A. (2024). Alzheimer's disease: A comprehensive review of epidemiology, risk factors, symptoms, diagnosis, management, caregiving, advanced treatments and associated challenges. Frontiers in Medicine, 11, Article 1474043. https://doi.org/10.3389/fmed.2024.1474043
Sepehrimanesh, M., Melen, S. V., Yeasmin, F., Ojo, V. A., Walden, F., Urmee, H., Etheridge, J., & Nasu, A. K. (2026). Emerging Therapeutic Strategies for Neurodegenerative Diseases: A Comprehensive Review of Recent Advances and Future Directions. Cells, 15(10), 928. https://doi.org/10.3390/cells15100928
Shawkatova, I., & Javor, J. (2025). Alzheimer's Disease: Recent Developments in Pathogenesis, Diagnosis, and Therapy. Life (Basel, Switzerland), 15(4), 549. https://doi.org/10.3390/life15040549
Sugandhi, V. V., Gadhave, D. G., Ugale, A. R., Kulkarni, N., Nangare, S. N., Patil, H. P., Rath, S., Saxena, R., Lavate, A., Patel, A. T., Jadhav, A., & Paudel, K. R. (2025). Advances in Alzheimer's therapy: Exploring neuropathological mechanisms to revolutionize the future therapeutic landscape. Ageing Research Reviews, 109, Article 102775. https://doi.org/10.1016/j.arr.2025.102775
Sunderland, A., Thatcher, A. L., Rackley, E. V., & Kuruvilla, T. (2025). Advances in diagnostics and treatments for Alzheimer’s disease. British Journal of Hospital Medicine, 86(12). https://doi.org/10.12968/hmed.2025.0492
Sushma, & Srivastava, V. K. (2024). Alzheimer's disease: Emerging therapies, diagnostic innovations, and future prospects. International Journal of Pharmaceutical Sciences, 2(8), 3437–3444. https://doi.org/10.5281/zenodo.13346603
Thawabteh, A. M., Ghanem, A. W., AbuMadi, S., Thaher, D., Jaghama, W., Karaman, D., & Karaman, R. (2024). Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease. Molecules, 29(21), 5131. https://doi.org/10.3390/molecules29215131
Tondo, G., De Marchi, F., Bonardi, F., Menegon, F., Verrini, G., Aprile, D., Anselmi, M., Mazzini, L., & Comi, C. (2024). Novel Therapeutic Strategies in Alzheimer’s Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond. Journal of Clinical Medicine, 13(11), 3098. https://doi.org/10.3390/jcm13113098
Wu, C. K., & Fuh, J. L. (2025). A 2025 update on treatment strategies for the Alzheimer's disease spectrum. Journal of the Chinese Medical Association: JCMA, 88(7), 495–502. https://doi.org/10.1097/JCMA.0000000000001252
Xing, H., Yue, S., Qin, R., Du, X., Wu, Y., Zhangsun, D., & Luo, S. (2025). Recent Advances in Drug Development for Alzheimer’s Disease: A Comprehensive Review. International Journal of Molecular Sciences, 26(8), 3905. https://doi.org/10.3390/ijms26083905
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024). Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies. Signal Transduction and Targeted Therapy, 9, Article 211. https://doi.org/10.1038/s41392-024-01997-z
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2026 Niko Koridze (Autor/a)
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Os autores que publicam na Revista Metropolitana de Ciencias Aplicadas (REMCA), concordam com os seguintes termos:
1. Direitos autorais
Os autores mantêm direitos autorais irrestritos sobre suas obras. Os autores concedem ao periódico o direito de primeira publicação. Para tal, cedem à revista, em caráter não exclusivo, direitos de exploração (reprodução, distribuição, comunicação pública e transformação). Os autores podem firmar acordos adicionais para a distribuição não exclusiva da versão publicada do trabalho no periódico, desde que haja reconhecimento de sua publicação inicial nesta revista.
© Os autores.
2. Licença
Os trabalhos são publicados na revista sob a licença Creative Commons Atribuição-NãoComercial-CompartilhaIgual 4.0 Internacional (CC BY-NC-SA 4.0). Os termos podem ser encontrados em: https://creativecommons.org/licenses/by-nc-sa/4.0/deed.pt
Esta licença permite:
- Compartilhar: copiar e redistribuir o material em qualquer meio ou formato.
- Adaptar: remixar, transformar e desenvolver o material.
Nos seguintes termos:
- Atribuição: Você deve dar o crédito apropriado, fornecer um link para a licença e indicar se alguma alteração foi feita. Você pode fazer isso de qualquer maneira razoável, mas não de uma forma que sugira que o licenciante endossa ou patrocina seu uso.
- Não comercial: você não pode usar o material para fins comerciais.
- Compartilhamento pela mesma licença: se você remixar, transformar ou criar a partir do material, deverá distribuir sua criação sob a mesma licença do trabalho original.
Não há restrições adicionais. Você não pode aplicar termos legais ou medidas tecnológicas que restrinjam legalmente outros de fazerem qualquer coisa que a licença permita.
